Παραπομπή APA

Xu, M., Liu, Z., Wang, C., Yao, B., & Zheng, X. (2017). EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling. Oncotarget.

Παραπομπή Chicago Style

Xu, Meng, Zhikui Liu, Cong Wang, Bowen Yao, και Xin Zheng. "EDG2 Enhanced the Progression of Hepatocellular Carcinoma By LPA/PI3K/AKT/ MTOR Signaling." Oncotarget 2017.

Παραπομπή MLA

Xu, Meng, et al. "EDG2 Enhanced the Progression of Hepatocellular Carcinoma By LPA/PI3K/AKT/ MTOR Signaling." Oncotarget 2017.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.